Eqrx Inc (EQRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EQRX | ELVN | AVDL | ||
| Company | Eqrx Inc | Enliven Therapeutics Inc | Avadel Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.39 | 25.50 | 11.76 | ||
| High | 2.42 | 26.09 | 12.22 | ||
| Low | 2.32 | 24.36 | 11.53 | ||
| Last | 2.34 | 24.54 | 11.66 | ||
| Change | -0.05 | -0.87 | unch | ||
| % Change | -2.09% | -3.42% | unch | ||
| Volume | 16,554,600 | 259,800 | 1,576,800 | ||
| 20-Day Average Volume | 4,083,095 | 249,290 | 1,742,045 | ||
| Previous Close | 2.39 | 25.41 | 11.66 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.26 | 27.03 | 13.27 | ||
| 20-Day Raw Stochastic | 53.66% | 13.80% | 20.00% | ||
| 20-Day Relative Strength | 55.03% | 40.91% | 41.09% | ||
| Weighted Alpha | -18.40 | +30.25 | +4.04 | ||
| Today's Opinion | 96% Buy | 40% Buy | 88% Sell | ||
| Previous Opinion | 96% Buy | 56% Buy | 88% Sell | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.54% since 11/01/23 | +0.53% since 11/15/24 | +6.87% since 11/15/24 | ||
| Low | 2.23 on 11/02/23 | 24.13 on 11/18/24 | 10.41 on 11/19/24 | ||
| High | 2.63 on 11/03/23 | 26.48 on 11/20/24 | 12.22 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +5.41% since 10/06/23 | -15.32% since 10/22/24 | -14.77% since 10/22/24 | ||
| Low | 2.01 on 10/30/23 | 23.70 on 11/15/24 | 10.41 on 11/19/24 | ||
| High | 2.63 on 11/03/23 | 29.78 on 11/07/24 | 16.66 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +4.46% since 08/08/23 | +7.16% since 08/22/24 | -27.89% since 08/22/24 | ||
| Low | 2.01 on 10/30/23 | 21.34 on 08/30/24 | 10.41 on 11/19/24 | ||
| High | 2.63 on 11/03/23 | 30.03 on 10/18/24 | 16.66 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +27.17% since 05/08/23 | +7.21% since 05/22/24 | -26.30% since 05/22/24 | ||
| Low | 1.60 on 05/09/23 | 19.52 on 06/07/24 | 10.41 on 11/19/24 | ||
| High | 2.63 on 11/03/23 | 30.03 on 10/18/24 | 17.30 on 08/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,140,551 | 1,199,000 | 1,123,581 | ||
| Shares Outstanding, K | 487,415 | 48,859 | 96,362 | ||
| Annual Sales | 0 | 0 | 27,960,000 | ||
| Annual Net Income | -169,090,000 | -71,580,000 | -160,280,000 | ||
| Last Quarter Sales | 0 | 0 | 50,030,000 | ||
| Last Quarter Net Income | -72,960,000 | -23,160,000 | -2,630,000 | ||
| 60-Month Beta | 0.48 | 1.08 | 1.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 08/08/23 | -0.48 on 11/13/24 | -0.03 on 11/12/24 | ||
| Latest Earnings Date | 11/09/23 | 11/14/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||